Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Category Systematic review
JournalBLOOD
Year 2020
This article has no abstract
Epistemonikos ID: 7eb70deecd2e3faa9c384ffca8e9ee8bc030fa5b
First added on: Feb 12, 2025